D
BioVaxys Technology Corp. BVAXF
$0.0389 $0.00010.26%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2024 04/30/2024 01/31/2024 10/31/2023 07/31/2023
Net Income 59.08% 63.65% 154.10% 57.96% -198.67%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -40.62% -98.89% -1,126.66% -71.10% 1,753.15%
Change in Net Operating Assets -174.28% 145.53% -38.47% 165.89% -9.66%
Cash from Operations -1,591.01% 38.73% 100.76% 99.05% 69.78%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 7.67% 289.60% -100.00% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- 2.49% 288.98% -100.00% --
Foreign Exchange rate Adjustments 96.88% 100.00% -600.00% 115.08% -420.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,251.43% -1,766.35% 1,470.63% -99.48% 63.73%
Weiss Ratings